Intermittent fasting may increase the risk of muscle loss, digestive issues, and energy crashes
Do any of these apply to you
The FDA-approved Wegovy label, for example, describes semaglutide as a GLP-1 receptor agonist used with reduced calories and increased physical activity for long-term weight reduction in certain adults and adolescents, and for reducing risk of major cardiovascular events in certain adults with cardiovascular disease and overweight or obesity
Upper arm: The back side of your upper arm, if someone else is giving you the injection
This unique synergistic effect is why it is currently the subject of such intense study regarding metabolic efficiency and lipolysis (fat breakdown)
Medical conditions, hormonal imbalances, and certain medications may also impact weight loss